Insight I Sino Bioengineering

In research and industrial production of protein science, protein separation, purification and concentration constitute pivotal steps governing experimental outcomes. As a core sepa……

Against the explosive growth of gene therapies and mRNA vaccines in biopharmaceuticals, plasmid DNA (pDNA) as a core raw material demands rigorous optimization of its manufacturing ……

At the cutting edge of biopharmaceuticals, gene therapies and novel vaccines (e.g., mRNA vaccines, viral vector vaccines) are transforming humanity’s arsenal against diseases at an ……

In the history of biopharmaceutical advancement, the rise of mRNA vaccines represents an unparalleled revolution in speed and manufacturing efficiency. Unlike conventional vaccines,……

As one of the most widely adopted nanomedicine delivery systems to date, liposomes, first discovered in the 1960s, have been extensively deployed in anti-tumor therapeutics, nucleic……

In the biopharmaceutical industry, fusion proteins stand out as promising therapeutic biologics, as they integrate two or more distinct functional proteins into a single molecular c……

In the downstream bioprocess of biopharmaceuticals, depth filtration stands as the primary clarification method for cell culture and fermentation broths, owing to its high dirt-hold……

With the rapid advancement of molecular biology and genetic engineering, technologies including mRNA vaccines, siRNA therapeutics, ASO drugs, gene editing, cell therapy, and in vivo……

Within the biopharmaceutical sector, the core objective of mixing operations is to homogeneously disperse diverse components via mechanical agitation to form a stable, uniform syste……

In recent years, nucleic acid drugs represented by mRNA technology have completely revolutionized the landscape of traditional vaccines and gene therapies. What many people fail to ……

Particle size stands as a make-or-break critical parameter in the in vivo delivery journey of mRNA-LNP therapeutics. Unlike mRNA, which encodes biological instructions, or ionizable……

Within the quality control framework of mRNA-LNP therapeutics, one metric weighs heavier on production costs than particle size and exerts a more direct impact on clinical efficacy ……

In the development and quality control of mRNA-LNP formulations, entrapment efficiency (EE) ranks among the most frequently tested critical quality attributes (CQAs). This metric re……

Within the quality control framework for mRNA-LNP therapeutics, particle size and polydispersity index (PDI) are invariably the first and most frequently tested critical indicators.……

Within the biopharmaceutical industry, the core objective of mixing processes is to homogeneously disperse distinct components via mechanical agitation, thereby forming a stable, un……

For structurally intricate and conformationally labile molecules such as bispecific antibodies (bsAbs) and trispecific antibodies (tsAbs), downstream purification workflows must shi……